TOP TIERMARKET NEWSWIRE
SEC Form 4 history

AMYLYX PHARMACEUTICA (AMLX) insider trades

AMYLYX PHARMACEUTICA (AMLX) insider trading activity (SEC Form 4). Over the trailing 90 days, AMLX insiders filed 0 purchases totalling $0 and 6 sales totalling $3.5M — net SELLING of $3.5M. Most recent filing: Sep 14, 2026. Insider transactions are a Pro-tier alertable signal in the live Top Tier Newswire terminal — Form 4 filings reach the wire within minutes of acceptance by the SEC. Data shown publicly here is delayed 4 hours.

Public view, delayed 4h. Real-time alerting on insider filings is a Pro feature.Open in the live terminal →
Buys (90d)
0
$0
Sells (90d)
6
$3.5M
Net (90d)
-$3.5M
net selling
Most recent
Sep 14, 2026

Recent transactions

FiledInsiderRoleTypeSharesPriceValue
Sep 14, 2026Cohen Joshua BCo-CEOS Sale—$32.19$981Kfiling
Sep 14, 2026Klee Justin B.Co-CEOS Sale—$32.18$980Kfiling
Sep 14, 2026Mazzariello GinaGCS Sale—$32.46$310Kfiling
Sep 14, 2026Frates James MCFOS Sale—$32.36$350Kfiling
Sep 14, 2026Bedrosian Camille LChief Medical OfficerS Sale—$32.40$325Kfiling
Jul 13, 2026Mazzariello GinaGCS Sale—$17.96$539Kfiling